cabergoline has been researched along with Uterine Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciebiera, M; Jakiel, G; Męczekalski, B; Słabuszewska-Jóźwiak, A; Wojtyła, C; Łukaszuk, K | 1 |
| Centini, G; Kashani, BN; Morelli, SS; Petraglia, F; Weiss, G | 1 |
| Ghaziani, N; Kashanian, M; Sheikhansari, N; Vahdat, M | 1 |
| Gharabaghi, PM; Mobasseri, M; Ouladsahebmadarek, E; Rahmani, V; Sayyah-Melli, M | 1 |
| Dastranj-Tabrizi, A; Farzadi, L; Gatrehsamani, F; Kazemi-Shishvan, M; Morteza, G; Ouladesahebmadarek, E; Sayyah-Melli, M; Tehrani-Gadim, S | 1 |
| Farzadi, L; Madarek, EO; Melli, MS | 1 |
2 review(s) available for cabergoline and Uterine Neoplasms
| Article | Year |
|---|---|
Alternative Oral Agents in Prophylaxis and Therapy of Uterine Fibroids-An Up-to-Date Review.
Topics: Administration, Oral; Antineoplastic Agents; Aromatase Inhibitors; Cabergoline; Catechin; Ergocalciferols; Ergolines; Female; Humans; Hydrocarbons, Fluorinated; Leiomyoma; Pyrimidines; Quality of Life; Uterine Neoplasms; Vitamin D | 2017 |
Role of Medical Management for Uterine Leiomyomas.
Topics: Antifibrinolytic Agents; Aromatase Inhibitors; Cabergoline; Cholecalciferol; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Danazol; Dopamine Agonists; Ergolines; Estrenes; Estrogen Antagonists; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Patient Care Planning; Selective Estrogen Receptor Modulators; Somatostatin; Tranexamic Acid; Uterine Neoplasms; Vitamins | 2016 |
4 trial(s) available for cabergoline and Uterine Neoplasms
| Article | Year |
|---|---|
Evaluation of the effects of cabergoline (Dostinex) on women with symptomatic myomatous uterus: a randomized trial.
Topics: Adult; Antineoplastic Agents; Cabergoline; Ergolines; Female; Humans; Leiomyoma; Single-Blind Method; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms; Young Adult | 2016 |
Comparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression,a randomized clinical trial.
Topics: Adult; Antineoplastic Agents; Aromatase Inhibitors; Cabergoline; Drug Therapy, Combination; Ergolines; Female; Humans; Leiomyoma; Letrozole; Middle Aged; Nitriles; Triazoles; Uterine Neoplasms; Uterus | 2017 |
Comparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine myoma growth. Histologic, sonographic, and intra-operative changes.
Topics: Adult; Antineoplastic Agents; Cabergoline; Dopamine Agonists; Ergolines; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Middle Aged; Treatment Outcome; Ultrasonography; Uterine Neoplasms | 2009 |
Comparison of the effect of gonadotropin-releasing hormone analog (Diphereline) and Cabergoline (Dostinex) treatment on uterine myoma regression.
Topics: Adult; Biopsy, Needle; Cabergoline; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Infusions, Intravenous; Leiomyoma; Middle Aged; Neoplasm Staging; Prospective Studies; Risk Assessment; Treatment Outcome; Uterine Neoplasms | 2007 |